Navigation Links
Bradmer provides clinical trial update and announces evaluation of strategic alternatives
Date:2/17/2009

TSX: BMR

TORONTO, Feb. 17 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc. (BMR.TSX), provided an update today on the ongoing Phase III GLASS-ART Trial testing Neuradiab(R) in the most advanced form of brain cancer (glioblastoma). Bradmer also announced that its Board of Directors has recommended a review of strategic options in light of performance, market conditions and new projections of site initiation and patient enrollment from the Company's clinical research organization (CRO).

During the second half of 2008, the Phase III GLASS-ART Trial was successfully launched with five clinical trial sites activated and another 15 sites near initiation with regulatory and budgeting processes completed. Bradmer has now also completed a review of the first cohort of patients.

"We have enrolled our first cohort of patients in the trial and documented the appropriateness of dosing and protocol compliance with no reports of any serious adverse events," said Dr. Alan M. Ezrin, President and Chief Executive Officer. "While the efficiency and quality review of the Phase III study to date yielded encouraging protocol adherence and proof of execution, it also revealed significant logistical issues."

The Company's present CRO has indicated that it is unable to meet the targets for site initiation and enrollment of sufficient patients in a timely manner. This has occurred despite Bradmer having secured participation of multiple key centers across the United States. This projected delay in patient enrollment translates into a longer time to reach key clinical milestones that would require additional capital beyond 2009 to complete a planned 60-patient "run-in phase" and full trial enrollment.

The Company has terminated the relationship with the CRO which has agreed to continue through any "transition" or "wind down" phase. Management and the Board of Directors of Bradmer are now examining the ramification of this delay and
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Bradmer to participate in panel presentation at RBC Capital Markets Healthcare Conference
2. Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at Society for Neuro-Oncology Meeting
3. Bradmer announces 2008 third quarter operational and financial results
4. Bradmer to present at Rodman & Renshaw Healthcare Conference
5. Bradmer receives FDA approval to proceed with Phase III clinical trial
6. Bradmer announces 2008 first quarter operational and financial results
7. Bradmer announces new additions to management team
8. Bradmer announces 2007 fourth quarter and fiscal year operational and financial results
9. Notice of Bradmer Pharmaceuticals Conference Call
10. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
11. Bradmer to present at the 10th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... 2014 Robins & Morton received ... Builders and Contractors (ABC) of Alabama. , ABC ... held at Sheraton Birmingham Hotel., , ... Million to $25 Million, Obelisk Award (First Place) ... Government $10 Million to $25 Million, Obelisk Award ...
(Date:10/2/2014)... Australia (PRWEB) October 02, 2014 ... markets, organic food is becoming increasingly popular with ... Organic Livestock and Poultry Farming industry in ... “the popularity of organic meat has surged over ... and expansion at the farming level.” Over the ...
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, Oct. 1, 2014 (HealthDay ... long-acting implanted devices -- could slash pregnancy and abortion rates ... In a study of 1,400 teenage girls, researchers found ... of unplanned pregnancy and abortion. Over three years, their annual ... rate of 158 per 1,000 among all sexually active teenage ...
(Date:10/2/2014)... have pinpointed a molecule that may trigger potentially life-threatening ... say this finding could offer a target for new ... Most asthma attacks (80 percent to 90 percent) are ... the British researchers. Most of these are rhinoviruses, which ... The researchers found that a specific molecule called IL-25 ...
(Date:10/2/2014)... WEDNESDAY, Oct. 1, 2014 (HealthDay News) -- Children with ... but they,re fully capable of being more active, a ... activity levels of 29 children, some with autism and ... per day of moderate physical activity and 70 more ... The 17 children with autism scored lower on strength, ...
Breaking Medicine News(10 mins):Health News:Robins & Morton wins nine awards from Associated Builders and Contractors 2Health News:Organic Livestock and Poultry Farming in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Organic Livestock and Poultry Farming in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Organic Livestock and Poultry Farming in Australia Industry Market Research Report Now Available from IBISWorld 4Health News:Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate 2Health News:Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate 3Health News:Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate 4Health News:New Clues to How Colds Can Spur Asthma Attacks 2Health News:Kids With Autism Tend to Be Less Active, Study Says 2
... hospitals throughout Indiana are now connected ... Physicians and patients at the Howard Regional Health ... from the clinical information exchanged through Indiana Health ... health care providers have implemented IHIE,s secure, Web-based ...
... Frost & Sullivan presented 20 awards ... sector at the 2009 Frost & Sullivan ... today at the InterContinental hotel in Singapore. (Logo: ... the awards banquet recognised companies across pharmaceuticals, clinical ...
... turning to a new trend to let others ... A case report will be presented Friday, May ... (AACE) 18th Annual Meeting & Clinical Congress shedding ... from the medical community. (Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b ...
... for Leadership Vision and Achievements in Advancing Health ... The Workgroup for Electronic Data Interchange is honoring ... Halvorson, with the 2009 Louis Sullivan Award. ... through their leadership vision and achievements in advancing ...
... in Mid-Atlantic RegionDENVER, April 21 Global ... "Company") (OTC Bulletin Board: GLOB), an international ... its Wyndgate Technologies(R) division has licensed its ... Donor Doc(TM) electronic donor history questionnaire to ...
... Care Brand Gains Another Top RecognitionFORT WORTH, Texas, ... moisturizers, currently the #1 Dermatologist Recommended brand of ... pediatricians. Cetaphil(R) products are specially formulated to provide ... look and feel its best, and the brand ...
Cached Medicine News:Health News:Kokomo Hospitals Implement Indiana Health Information Exchange Clinical Messaging Service 2Health News:Kokomo Hospitals Implement Indiana Health Information Exchange Clinical Messaging Service 3Health News:Outstanding Healthcare Companies in Asia Pacific Honored 2Health News:Outstanding Healthcare Companies in Asia Pacific Honored 3Health News:Outstanding Healthcare Companies in Asia Pacific Honored 4Health News:Outstanding Healthcare Companies in Asia Pacific Honored 5Health News:New Research Reveals Need for Doctors to Know About Medical Tattoos 2Health News:Kaiser Permanente CEO George Halvorson Receives National Award From the Workgroup for Electronic Data Interchange 2Health News:Kaiser Permanente CEO George Halvorson Receives National Award From the Workgroup for Electronic Data Interchange 3Health News:Global Med Technologies(R) Licenses ElDorado(TM) Software Solutions to $3.5 Billion MedStar Health of Baltimore, MD 2Health News:Global Med Technologies(R) Licenses ElDorado(TM) Software Solutions to $3.5 Billion MedStar Health of Baltimore, MD 3Health News:Global Med Technologies(R) Licenses ElDorado(TM) Software Solutions to $3.5 Billion MedStar Health of Baltimore, MD 4Health News:Cetaphil(R) Cleansers and Moisturizers Now the #1 Pediatrician Recommended Brand 2
(Date:10/2/2014)... 2, 2014  MinuteClinic, the largest and fastest growing provider of ... has opened its first walk-in clinics in the Corpus ... Corpus Christi and Portland . ... in December. The clinics are part of MinuteClinic,s ... With the Corpus Christi -area openings, there are ...
(Date:10/2/2014)... 2, 2014   Mast Therapeutics, Inc. (NYSE ... Edwin L. Parsley , D.O. has joined the ... President.  Dr. Parsley has been actively engaged ... in February 2014.  He has served as Mast,s interim ... Medical Officer of Aires since April 2011.  Dr. Parsley ...
(Date:10/1/2014)... CITY, Calif. , Oct. 1, 2014  Abaxis, ... company manufacturing point-of-care instruments and consumables for the medical, ... services to the veterinary and research markets in ... has entered into a definitive distribution agreement with Patterson ... market and promote the full line of Abaxis veterinary ...
Breaking Medicine Technology:First MinuteClinic Walk-in Medical Clinics Open in Corpus Christi 2First MinuteClinic Walk-in Medical Clinics Open in Corpus Christi 3Mast Therapeutics Announces Appointment Of Chief Medical Officer 2Mast Therapeutics Announces Appointment Of Chief Medical Officer 3Mast Therapeutics Announces Appointment Of Chief Medical Officer 4Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 2Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 3Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 4
... /PRNewswire-Asia/ -- Chindex International, Inc. (Nasdaq: CHDX ... providing health care services in China through the operations ... primary care hospitals and affiliated ambulatory clinics, today announced ... ended December 31, 2010. Presentation of ...
... American Association for Homecare strongly endorses bipartisan legislation to ... program for home medical equipment and services (durable medical ... Glenn Thompson (R-Pa.) and Jason Altmire (D-Pa.) on March ... Bidding Act."   Tyler Wilson, president ...
Cached Medicine Technology:Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010 2Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010 3Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010 4Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010 5Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010 6Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010 7Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010 8Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010 9Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010 10Home Medical Equipment Group Supports Bipartisan Bill to Repeal the Controversial Medicare 'Competitive' Bidding Program for Homecare 2Home Medical Equipment Group Supports Bipartisan Bill to Repeal the Controversial Medicare 'Competitive' Bidding Program for Homecare 3